DowPharma: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market
Global PDF: US$ 4,100.00
A strategies assessment of DowPharma, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.
Contains 53 pages and 5 tables
A strategies assessment of DowPharma, one of the world's leading life science intermediates companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global life science intermediates market.
Contains 53 pages and 5 tables
I. EXECUTIVE SUMMARY
II. BUSINESS ORGANIZATION
III. SENIOR MANAGEMENT
IV. FACILITIES AND EMPLOYEES
V. TECHNOLOGICAL KNOW-HOW
VI. PRODUCT PORTFOLIO
VII. MARKETING TACTICS
VIII. SALES AND PROFIT GROWTH
IX. R&D EXPENDITURES AND MAJOR PROGRAMS
X. COLLABORATIVE ARRANGEMENTS
XI. STRATEGIC DIRECTION
LIST OF TABLES
Table 1: Sales and Operating Profit Growth
Table 2: Sales by Operating Segment
Table 3: Sales Growth by Operating Segment
Table 4: Sales by Geographic Region
Table 5: Sales Growth by Geographic Region
II. BUSINESS ORGANIZATION
III. SENIOR MANAGEMENT
IV. FACILITIES AND EMPLOYEES
V. TECHNOLOGICAL KNOW-HOW
VI. PRODUCT PORTFOLIO
VII. MARKETING TACTICS
VIII. SALES AND PROFIT GROWTH
IX. R&D EXPENDITURES AND MAJOR PROGRAMS
X. COLLABORATIVE ARRANGEMENTS
XI. STRATEGIC DIRECTION
LIST OF TABLES
Table 1: Sales and Operating Profit Growth
Table 2: Sales by Operating Segment
Table 3: Sales Growth by Operating Segment
Table 4: Sales by Geographic Region
Table 5: Sales Growth by Geographic Region
